Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Levocetirizine 5 mg tablet vs XYZAL 5 mg in healthy Thai volunteers (fasting)
TCTR20210422002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levocetirizine in allergic rhinitis (AR) and chronic urticaria (CU) (2 arms), sponsored by Bio-innova. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)chronic urticaria (CU)
Beyond the preview
Go deeper on TCTR20210422002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210422002.